Neonatal and infant feeding disorders program saves infants from lifetime of feeding tubes

Innovative feeding strategy improves infant feeding and saves millions a year in health-care costs

 

Columbus, Ohio USA (September 6, 2011 – An innovative approach to treating neonatal feeding problems at Nationwide Children’s Hospital has allowed infants who were struggling to feed orally to be discharged earlier and without feeding tubes, subsequently saving millions of annual healthcare charges.

 

According to American Academy of Pediatrics guidelines, in order for premature infants to be discharged from the hospital, they must establish safe oral feeding methods. The prevalence of feeding problems in once-premature infants is twice that of full-term infants and often prolongs hospitalization for these babies. Infants who fail to gain skills necessary to feed orally often receive gastrostomy tubes, tubes placed within a baby’s stomach through which he/she can receive nutrition. For the first year, home gastrostomy feeding methods cost nearly $47,000.

 

The study, appearing in the Journal of Pediatric Gastroenterology and Nutrition, details outcomes for 100 neonatal intensive care unit (NICU) infants referred to the Neonatal and Infant Feeding Disorders Program at Nationwide Children’s for a feeding strategy in an effort to avoid gastrostomy placement. Their feeding capabilities were detailed at birth, at the time of feeding evaluation, at discharge and at 1 year of age.

 

Because they received an individualized feeding strategy, 51 percent of these infants were feeding successfully upon discharge and 84 percent at 1 year of age. Even among the gastrostomy infants, the vast majority of patients went on to recover significant oral motor skills.

 

The integrated feeding strategy led to a higher feeding success than traditional methods. Of 50 infants who received conventional treatment in years prior to the Neonatal and Infant Feeding Disorders Program, 10 percent were feeding orally at discharge and 42 percent at 1 year of age.

 

"Being able to successfully develop feeding strategies for these infants provides them a greatly improved quality of life, improves parental satisfaction and leads to a reduced economic burden," said Sudarshan Jadcherla, MD, FRCPI, DCH, AGAF, Nationwide Children’s Hospital neonatologist and principal investigator in the Center for Perinatal Research, medical director of the Neonatal and Infant Feeding Disorders Program at Nationwide Children’s and lead author of the study. Among the 100 infants in this study, there was an estimated $3.8 million cost savings over one year – $2.1 million in savings from avoided gastrostomy tube placement, $1.7 million in savings because of earlier discharge from the hospital.

 

Dr. Jadcherla, also professor of Pediatrics at The Ohio State University College of Medicine and Public Health, says the strength of the feeding strategy described in this study lies in the fact that it is multidisciplinary, individualized and evidence-based. First, clinicians documented each infant’s feeding difficulty symptoms and noted any underlying disease. Each infant underwent specialized pharyngo-esophageal manometry and swallow studies to evaluate the structure and function of his/her aerodigestive system. Further studies and input from a multidisciplinary team helped characterize the mechanisms of each infant’s feeding difficulty and their symptoms. These findings were discussed with parents. An individualized feeding management strategy was developed for each infant with special emphasis on feeding mechanics, feeding methods, co-morbidities, nutrition and growth. Finally, nurses, feeding therapists and parents were educated on the baby’s feeding plan.

 

"This is the first study to describe an innovative approach to diagnose feeding problems and implement management strategies to improve oral feeding outcomes at discharge and followed at 1-year, among complex NICU infants expected to receive gastrostomy tubes," said Dr. Jadcherla.

 

 

 

 


Nationwide Children’s Hospital, 06.09.2011 (tB).

MEDICAL NEWS

Fitness watches generate useful information, but increase patient anxiety
A new device provides added protection against COVID-19 during endoscopic…
81 million Americans lacking space or bathrooms to follow COVID…
Front-line physicians stressed and anxious at work and home
EULAR: High-Dose Glucocorticoids and IL-6 Receptor inhibition can reduce COVID-19…

SCHMERZ PAINCARE

Krankenhäuser und Praxen müssen sich bei der Schmerztherapie nach Operationen…
Morbus Fabry mittels Datenanalysen aus dem PraxisRegister Schmerz aufspüren
Neandertaler besaßen niedrigere Schmerzschwelle
Deutscher Schmerz- und Palliativtag 2020 – ONLINE
Deutsche Gesellschaft für Schmerzmedizin fordert Anerkennung von Nicht-Psychologen in der…

DIABETES

“Körperstolz”: Michael Krauser managt seinen Diabetes digital
Der richtige Sensor – von Anfang an
Diabetes mellitus: Ein Risikofaktor für frühe Darmkrebserkrankungen
Fastenmonat Ramadan: Alte und neue Herausforderung für chronisch Erkrankte während…
Sanofi setzt sich für die Bedürfnisse von Menschen mit Diabetes…

ERNÄHRUNG

Corona-Erkrankung: Fehl- und Mangelernährung sind unterschätze Risikofaktoren
Gesundheitliche Auswirkungen des Salzkonsums bleiben unklar: Weder der Nutzen noch…
Fast Food, Bio-Lebensmittel, Energydrinks: neue Daten zum Ernährungsverhalten in Deutschland
Neue Daten zur Ernährungssituation in deutschen Krankenhäusern und Pflegeheimen: Mangelernährung…
Baxter: Parenterale Ernährung von Patienten mit hohem Aminosäurenbedarf

ONKOLOGIE

Bestmögliche Versorgungssicherheit bei der Krebstherapie mit CAR-T-Zellen
Darolutamid bei Prostatakarzinom: Hinweis auf beträchtlichen Zusatznutzen
Multiples Myelom: Wissenschaftler überprüfen den Stellenwert der Blutstammzelltransplantation
Neues zur onkologischen Supportiv- und Misteltherapie und aktuelle Kongress-Highlights zum…
Neue Darreichungsform zur Antiemese bei Chemotherapie: Akynzeo® ist ab sofort…

MULTIPLE SKLEROSE

Geschützt: Multiple Sklerose: Novartis’ Siponimod verzögert Krankheitsprogression und Hirnatrophie bei…
Neurofilamente als Diagnose- und Prognosemarker für Multiple Sklerose
Bedeutung der Langzeittherapie bei Multipler Sklerose – mehr Sicherheit und…
Bristol Myers Squibb erhält Zulassung der Europäischen Kommission für Ozanimod…
Einige MS-Medikamente könnten vor SARS-CoV-2/COVID-19 schützen

PARKINSON

Neue Studie zur tiefen Hirnstimulation bei Parkinson-Erkrankung als Meilenstein der…
Putzfimmel im Gehirn
Parkinson-Patienten in der Coronakrise: Versorgungssituation und ein neuer Ratgeber
Neuer Test: Frühzeitige Differenzialdiagose der Parkinson-Erkrankung
Gegen das Zittern: Parkinson- und essentiellen Tremor mit Ultraschall behandeln…